Liu, Edwin
Dilley, Deanne
McDonough, Belinda
Stockis, Armel
Daniels, Tony
Funding for this research was provided by:
UCB Pharma
Article History
First Online: 28 June 2019
Compliance with Ethical Standards
:
: This work was funded by UCB Pharma. UCB Pharma was responsible for the design and conduct of the trial, the collection, analysis, and interpretation of data, and was involved in the preparation and review of the manuscript. The authors made the final decision to submit the manuscript for publication. Open access was funded by UCB Pharma.
: Edwin Liu has no conflicts of interest that are directly relevant to the content of this article. Deanne Dilley was an employee of UCB Pharma when the trial was conducted and is currently employed by Statistics and Data Corporation. Belinda McDonough was an employee of UCB Pharma when the trial was conducted and is currently Director of MAFSAF Ltd. She has received stocks and stock options from UCB Pharma. Armel Stockis and Tony Daniels are employees of UCB Pharma. Armel Stockis has received stock options from UCB Pharma. Tony Daniels has received stocks from UCB Pharma.
: Informed consent was obtained from all individual participants included in the trial.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Due to the small sample size in this trial, individual patient data cannot be adequately anonymized and there is a reasonable likelihood that individual participants could be re-identified. For this reason, data from this trial cannot be shared.